tiprankstipranks
Heidelberg Pharma AG (DE:HPHA)
XETRA:HPHA

Heidelberg Pharma AG (HPHA) Cash flow

0 Followers

Heidelberg Pharma AG Cash Flow

DE:HPHA's free cash flow for Q4 2022 was €-11.06M. For the 2022 fiscal year, DE:HPHA's free cash flow was decreased by €18.52M and operating cash flow was €-10.74M. See a summary of the company’s cash flow.
Cash Flow
TTM
Nov 22Nov 21Nov 20Nov 19Nov 18
Operating Cash Flow
€ -13.08M€ -8.86M€ -26.61M€ -17.89M€ -8.56M€ -9.98M
Investing Cash Flow
€ -815.25K€ -597.57K€ -1.40M€ -1.29M€ -975.80K€ -1.00M
Financing Cash Flow
€ 74.00M€ 84.00M€ 29.17M€ 14.29M€ 0.00€ 0.00
Cash Flow From Discontinued Operation
------
Other Cash Adjustment Inside Changein Cash
------
End Cash Position
€ 174.88M€ 81.33M€ 6.14M€ 4.98M€ 9.88M€ 19.44M
Income Tax Paid Supplemental Data
------
Interest Paid Supplemental Data
------
Issuance Of Capital Stock
€ 79.91M€ 79.91M€ 20.02M€ 14.45M€ 0.00€ 0.00
Issuance Of Debt
-----€ 0.00
Repayment Of Debt
------
Free Cash Flow
€ -13.92M€ -9.48M€ -28.00M€ -19.33M€ -9.52M€ -10.98M
Domestic Sales
------
Foreign Sales
------
Currency in EUR

Heidelberg Pharma AG Cash Flow

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis